{"component": "definition", "props": {"groups": [{"samples": [{"hash": "5EwaeM4cXgj", "uri": "/contracts/5EwaeM4cXgj#development-milestone-event", "label": "Research Collaboration and License Agreement (Atrium Therapeutics, Inc.)", "score": 37.0793991089, "published": true}, {"hash": "imgJzxyx8tm", "uri": "/contracts/imgJzxyx8tm#development-milestone-event", "label": "Option and License Agreement (Evaxion Biotech a/S)", "score": 35.7488021851, "published": true}, {"hash": "kSh6R3UGCXQ", "uri": "/contracts/kSh6R3UGCXQ#development-milestone-event", "label": "Research Collaboration and License Agreement (Avidity Biosciences, Inc.)", "score": 31.3874053955, "published": true}], "size": 38, "snippet_links": [{"key": "section-721", "type": "clause", "offset": [29, 42]}], "snippet": "has the meaning set forth in Section 7.2.1.", "hash": "4e86c95c0cb14b00060d44fcf87bca43", "id": 1}, {"samples": [{"hash": "htD8TvNE9cf", "uri": "/contracts/htD8TvNE9cf#development-milestone-event", "label": "License Agreement (Legend Biotech Corp)", "score": 37.1861724854, "published": true}, {"hash": "dOuOAjFCuxP", "uri": "/contracts/dOuOAjFCuxP#development-milestone-event", "label": "License Agreement (Legend Biotech Corp)", "score": 36.1895942688, "published": true}, {"hash": "8zleXMiQzk0", "uri": "/contracts/8zleXMiQzk0#development-milestone-event", "label": "License Agreement (Legend Biotech Corp)", "score": 35.212184906, "published": true}], "size": 34, "snippet_links": [], "snippet": "shall have the meaning set forth in Section 9.2(a).", "hash": "b741682c340a3e05524c9aa8bf7c6055", "id": 2}, {"samples": [{"hash": "iWX7FNj2A6l", "uri": "/contracts/iWX7FNj2A6l#development-milestone-event", "label": "License and Collaboration Agreement (LianBio)", "score": 34.2347717285, "published": true}, {"hash": "957F4wASNpd", "uri": "/contracts/957F4wASNpd#development-milestone-event", "label": "License and Collaboration Agreement (Lyra Therapeutics, Inc.)", "score": 32.603012085, "published": true}, {"hash": "dqx1nA5AtKY", "uri": "/contracts/dqx1nA5AtKY#development-milestone-event", "label": "License and Collaboration Agreement (Landos Biopharma, Inc.)", "score": 32.57289505, "published": true}], "size": 30, "snippet_links": [{"key": "development-milestone-payment", "type": "clause", "offset": [45, 74]}], "snippet": "has the meaning set forth in Section 6.1(b) (Development Milestone Payment).", "hash": "2b374af162a65cef92eb6f617147abc8", "id": 3}, {"samples": [{"hash": "jhIRusgJkF1", "uri": "/contracts/jhIRusgJkF1#development-milestone-event", "label": "Global Transaction Agreement (BioAtla, Inc.)", "score": 35.7268981934, "published": true}, {"hash": "fNEj3uA8yKZ", "uri": "/contracts/fNEj3uA8yKZ#development-milestone-event", "label": "License Agreement (Context Therapeutics Inc.)", "score": 35.7268981934, "published": true}, {"hash": "d4mcn2DDLH0", "uri": "/contracts/d4mcn2DDLH0#development-milestone-event", "label": "License Agreement (BioAtla, Inc.)", "score": 35.7268981934, "published": true}], "size": 22, "snippet_links": [{"key": "section-421", "type": "clause", "offset": [29, 42]}], "snippet": "has the meaning set forth in Section 4.2.1;", "hash": "55bcbbf63e0fd00abea61867930b18ef", "id": 4}, {"samples": [{"hash": "3qqUPHm55j8", "uri": "/contracts/3qqUPHm55j8#development-milestone-event", "label": "Development and License Agreement (Precision Biosciences Inc)", "score": 34.508556366, "published": true}, {"hash": "kPm0GNzrycm", "uri": "/contracts/kPm0GNzrycm#development-milestone-event", "label": "Development and License Agreement (Precision Biosciences Inc)", "score": 32.2087593079, "published": true}], "size": 11, "snippet_links": [{"key": "section-93", "type": "clause", "offset": [29, 40]}], "snippet": "has the meaning set forth in Section 9.3.", "hash": "ec9b57bff0187d02e982a8ab640ba7c1", "id": 5}, {"samples": [{"hash": "hTPd1WodG9C", "uri": "/contracts/hTPd1WodG9C#development-milestone-event", "label": "Asset Purchase Agreement (Immunome Inc.)", "score": 35.0971946716, "published": true}, {"hash": "aae8TMy1KSh", "uri": "/contracts/aae8TMy1KSh#development-milestone-event", "label": "Asset Purchase Agreement (Ayala Pharmaceuticals, Inc.)", "score": 33.0971946716, "published": true}], "size": 9, "snippet_links": [], "snippet": "has the meaning set forth in Section 3.3(a).", "hash": "80431aee257b3923746286c46596eb43", "id": 6}, {"samples": [{"hash": "4HFt1kbnmTD", "uri": "https://www.sec.gov/Archives/edgar/data/873303/000119312518313968/d645222dex21.htm", "label": "Warrant to Purchase Common Stock (Sarepta Therapeutics, Inc.)", "score": 17.8295688629, "published": false}, {"hash": "hCo7FY8DciR", "uri": "https://www.sec.gov/Archives/edgar/data/873303/000156459018020534/srpt-ex21_195.htm", "label": "Warrant to Purchase Common Stock (Sarepta Therapeutics, Inc.)", "score": 17.5995883942, "published": false}, {"hash": "bC7qHpnPea3", "uri": "https://investorrelations.sarepta.com/static-files/12f15a64-614a-4dd1-b9d0-ba904f98dbab", "label": "investorrelations.sarepta.com", "score": 10.1704311371, "published": false}], "size": 5, "snippet_links": [{"key": "development-milestone-event-1", "type": "definition", "offset": [14, 43]}, {"key": "development-milestone-event-2", "type": "definition", "offset": [45, 74]}, {"key": "development-milestone-event-3", "type": "definition", "offset": [76, 105]}, {"key": "development-milestone-event-4", "type": "definition", "offset": [107, 136]}, {"key": "development-milestone-event-5", "type": "definition", "offset": [141, 170]}], "snippet": "means each of Development Milestone Event 1, Development Milestone Event 2, Development Milestone Event 3, Development Milestone Event 4 and Development Milestone Event 5.", "hash": "f0af6391c265ed9b2f99df6c460e1aa2", "id": 7}, {"samples": [{"hash": "gqhnd3pTAW4", "uri": "/contracts/gqhnd3pTAW4#development-milestone-event", "label": "License Agreement (Kiniksa Pharmaceuticals, Ltd.)", "score": 27.3175907135, "published": true}, {"hash": "fyroviTXbVZ", "uri": "/contracts/fyroviTXbVZ#development-milestone-event", "label": "License Agreement (Kiniksa Pharmaceuticals, Ltd.)", "score": 27.1560573578, "published": true}], "size": 5, "snippet_links": [{"key": "section-921", "type": "clause", "offset": [29, 42]}, {"key": "milestone-payments", "type": "clause", "offset": [44, 62]}], "snippet": "has the meaning set forth in Section 9.2.1 (Milestone Payments).", "hash": "04aee6ec0c00188ad0c17f12480330fa", "id": 8}, {"samples": [{"hash": "kGW0plT60ER", "uri": "/contracts/kGW0plT60ER#development-milestone-event", "label": "Option and License Agreement (Voyager Therapeutics, Inc.)", "score": 34.1772766113, "published": true}, {"hash": "56ZJ1zgJEQ2", "uri": "/contracts/56ZJ1zgJEQ2#development-milestone-event", "label": "Option and License Agreement (Voyager Therapeutics, Inc.)", "score": 33.3367538452, "published": true}], "size": 5, "snippet_links": [{"key": "milestone-event", "type": "clause", "offset": [10, 25]}], "snippet": "means any Milestone Event set forth in Section 5.4.1.", "hash": "18da4d6ff94faba3f2cd7629330b9f8c", "id": 9}, {"samples": [{"hash": "1TX7WVgkQWE", "uri": "/contracts/1TX7WVgkQWE#development-milestone-event", "label": "Collaboration and License Agreement (Nurix Therapeutics, Inc.)", "score": 31.4996585846, "published": true}], "size": 5, "snippet_links": [{"key": "section-1152", "type": "clause", "offset": [14, 28]}, {"key": "development-milestones", "type": "clause", "offset": [30, 52]}], "snippet": "is defined in Section 11.5.2 (Development Milestones).", "hash": "2a944863b9fe2cea50f31ebd16873309", "id": 10}], "next_curs": "CmgSYmoVc35sYXdpbnNpZGVyY29udHJhY3RzckQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIkZGV2ZWxvcG1lbnQtbWlsZXN0b25lLWV2ZW50IzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Development Milestone Event", "size": 205, "snippet": "has the meaning set forth in Section 7.2.1.", "id": "development-milestone-event", "examples": ["Following the earlier of (a) achievement of <strong>Development Milestone Event</strong> #2 and (b) January 1, 2028, Exact may terminate this Agreement in its entirety (for all Collaboration Products) in its sole discretion at any time upon [***] days\u2019 prior written notice to Freenome.", "A Party will notify the JSC in writing of the achievement of a <strong>Development Milestone Event</strong> by such Party or its Affiliates no later than [***] days following the date of achievement thereof.", "For clarity, in no event will the total amount payable to Freenome under this Section 8.2 (Development Milestone Payments), in the aggregate and taking into account any alternative milestones that may be payable, exceed Seven Hundred Million Dollars ($700,000,000) in the aggregate, assuming that each <strong>Development Milestone Event</strong> expressly set forth in Table 8.2.1 (Development Milestone Payments) were achieved."], "related": [["development-milestone", "Development Milestone", "Development Milestone"], ["milestone-event", "Milestone Event", "Milestone Event"], ["development-milestone-payment", "Development Milestone Payment", "Development Milestone Payment"], ["sales-milestone-event", "Sales Milestone Event", "Sales Milestone Event"], ["milestone-events", "Milestone Events", "Milestone Events"]], "related_snippets": [], "updated": "2026-04-30T06:05:53+00:00"}, "json": true, "cursor": ""}}